Global gene expression profiling studies have classified BC into four subtypes by hierarchical clustering, namely, the luminal A subtype, luminal B subtype, human epidermal growth factor receptor 2 (HER2)-overexpression subtype, and triple-negative subtype (triple-negative breast cancer, TNBC) [7]. Here, ERBB2 is linked to triple-negative breast carcinoma.